Autor:	M. Walbaum, R. Rojas
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry medicine.drug_class Health Policy Public Health Environmental and Occupational Health Atrial fibrillation Budget impact Vitamin K antagonist medicine.disease Dabigatran Internal medicine medicine Cardiology In patient business Absorption (electromagnetic radiation) medicine.drug
Zdroj:	Value in Health. 23:S97
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.04.143
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::da05020484d24b462721fe23129e63d9 https://doi.org/10.1016/j.jval.2020.04.143 Zobrazit plný text záznamu Full Text from ScienceDirect